Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.
Environmental factors in multiple sclerosis.
The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS.
Tadeusz Markiewicz - the researcher's profile and his role in the studies on neuromyelitis optica.
[Present and future of the transcranial magnetic stimulation].
Demyelinating neuropathy and autoimmune hemolytic anemia in a patient with pancreatic cancer.
Allogeneic Hematopoietic Stem Cell Transplantation for Neuromyelitis Optica.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Impaired decision-making and diffusion orientational complexity in people with multiple sclerosis.
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.
Association of sex hormones and glucose metabolism with the severity of multiple sclerosis.
A high throughput flow gradient LC-MS/MS method for simultaneous determination of fingolimod, fampridine and prednisone in rat plasma, application to in vivo perfusion study.
Clinical data and regulatory issues of biosimilar products.
Interferon beta assessment in non-Chinese and Chinese subjects: Pharmacokinetics and pharmacodynamic activity of an endogenous cytokine are not race dependent.
An epidemiological study of neuromyelitis optica in Isfahan.
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
7 tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
Remotely-supervised transcranial direct current stimulation (tDCS) for clinical trials: guidelines for technology and protocols.
Brain atrophy at onset and physical disability in multiple sclerosis.
Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica.
Images in clinical medicine. Bilateral internuclear ophthalmoplegia in multiple sclerosis.
A correlation study between multiple sclerosis and type 1 diabetes incidences and geochemical data in Europe.
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
How Patients With Multiple Sclerosis Perceive Cognitive Slowing.
Pages
« first
‹ previous
…
354
355
356
357
358
359
360
361
362
…
next ›
last »